Skip to content
NVOCUSIP 670100205NYSE · Health Care · Denmark

Novo Nordisk A S

Who owns Novo Nordisk A S? 2 of the investors we track held it at their latest disclosure: Markel Group, Baillie Gifford.

Tracked investor ownership

Figures cover Capital Signals' tracked investors only — not the company's full shareholder register.

Tracked investors

2

in latest disclosures

New positions

0

Increased

1

Reduced

0

Exited (confirmed)

0

Investor holdings

Tracked investors' latest disclosed holdings in Novo Nordisk A S
InvestorHoldingReported valuePortfolio weightActivityReporting periodSource
Markel Group2.87m$137.6m1.0%—Q2 2026

Filed 31 Jul 2026

Baillie Gifford205$8k0.0%IncreasedQ3 2026

Filed 9 Nov 2026

Historical ownership

Number of tracked investors whose most recent disclosure at each period end included Novo Nordisk A S.

Tracked investors disclosing Novo Nordisk A S by period
PeriodValue
Q4 20250
Q1 20260
Q2 20262
Q3 20262

Investor by investor

Portfolio weight in each disclosure. “—” means not reported in that disclosure.

Portfolio weight by investor and period
InvestorQ4 2025Q1 2026Q2 2026Q3 2026
Markel Groupn/dn/d1.0%n/d
Baillie Giffordn/dn/d0.0%0.0%

n/d: the investor did not publish a disclosure for that period.

An important qualification

The presence of a company in several tracked portfolios does not establish that it is a good investment. Disclosures may be delayed, positions may be immaterial, and investors may have different strategies, time horizons and reasons for holding the same security.

Related research